The CAR-T Landscape: Innovations, Challenges, and Future Directions
Have already registered
| Last name | First name | Organization |
|---|---|---|
| Anthonissen | Annelore | Johnson & Johnson Innovative Medicine |
| Bandarlipe| | Sarah Jane | Janssen-Cilag NV |
| Binst | Elke | - |
| Borginon | Irene | UZ Leuven |
| Brepoels | Alessandra | Axes Health BV |
| Buytaert | Dimitri | Janssen Pharmaceutica NV |
| Campion | Françoise | CSL Behring |
| Clement | Ann | Pharmeleon |
| Cools | Nathalie | University of Antwerp |
| Flumens | Donovan | University of Antwerp |
| franck | Morgane | PwC Belgium |
| Geelen | Steven | - |
| Geers | Janice | Janssen-Cilag NV |
| Gil Garcia | Karen | HUB - Institut Jules Bordet |
| Guarini | Nadia Pia | HR One Group BV |
| Guns | Laura-An | AstraZeneca nv/sa |
| Henkinet | Robert | Janssen-Cilag NV |
| Inzé | Annelies | Pfizer N.V. – S.A. |
| Janssens | Kristel | HealthA BV |
| Khaoutieva | Albina | Enterprise Ireland |
| Kinoo | Dominique | AstraZeneca nv/sa |
| Leloup | Roxane | Nuwhï |
| Lion | Eva | University of Antwerp |
| Lodewijckx | Inge | ELI LILLY Benelux sa/nv |
| Mergan | Stephanie | HEBIAS bv |
| Moretti Violato | Natalia | PwC Belgium |
| Paternotte | Nathalie | AstraZeneca nv/sa |
| Peeters | Frederik | Gsk |
| Ronsse | Damien | Galapagos NV |
| Tobback | Leen | Amgen Belgium nv |
| Van Den Broeck | Elise | J&J |
| Van den Eede | Caroline | Amgen Belgium nv |
| Van Dooren | Patrick | IQVIA |
| Van Rompaey | Philippe | UZ Gent - HIRUZ |
| Van Schoor | Evelien | AstraZeneca nv/sa |
| Vancaeneghem | Pieter | GILEAD Sciences Belgium bv |
| Vandewiele | Frone | Kintiga (AxTalis BV) |
| Vanneste | Bart | Janssen Pharmaceutica NV |
| Verheyen | Anne | CSL Behring |
| Vermeersch | Evelyne | Ad Hoc Clinical NV |
| Wambacq | Liske | Nuwhï |
| Weglewski | Tim | IQVIA |
| Willems | Micha | IQVIA |
| Winters | Karen | Novartis Pharma nv |
| Wyckmans | Charlotte | AstraZeneca nv/sa |